Thermal unfolding of antibodies

contributed by Nano Temper | 03/22/2016

Comparison of nanoDSF and µDSC for thermal stability assessment during biopharmaceutical formulation development

Assessing the thermal stability parameters of biologics is an integral part of formulation development in biopharmaceutical research. We compared two methods that detect thermal unfolding transition temperatures (Tm) of a therapeutic monoclonal antibody (mAb): nanoDSF, an advanced differential scanning fluorimetry method, which analyzes changes in the fluorescence emission properties of proteins, and differential scanning calorimetry (µDSC), which detects changes in the heat capacity of a protein solution upon unfolding. While both nanoDSF and µDSC provided precise and consistent data, the high-throughput and low sample consumption qualify nanoDSF as the ideal technology for thermal stability screening in biopharmaceutical development.

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!

Email*

Choose a password

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.